-
Je něco špatně v tomto záznamu ?
Isotype class switching after transplantation in multiple myeloma
V Maisnar, M Tichy, L Smolej, P Zak, J Radocha, V Palicka, J Maly, V Blaha
Jazyk angličtina Země Slovensko
- MeSH
- dospělí MeSH
- homologní transplantace MeSH
- imunoglobulinové izotypy metabolismus MeSH
- lidé středního věku MeSH
- lidé MeSH
- míra přežití MeSH
- mnohočetný myelom imunologie patologie terapie MeSH
- nemoc štěpu proti hostiteli MeSH
- paraproteinemie patologie MeSH
- paraproteiny imunologie MeSH
- přesmyk imunoglobulinových tříd MeSH
- prognóza MeSH
- retrospektivní studie MeSH
- senioři MeSH
- transplantace periferních kmenových buněk MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
Switching of the paraprotein isotype or transient presence of oligoclonal bands detectable by serum immunofixation electrophoresis has been reported following not only transplantations, but also after intensive chemotherapy for leukemia. Retrospective analysis of 72 transplanted myeloma patients was carried out to determine the frequency and clinical significance of the appearance of abnormal proteins bands (APB) distinct from the original paraprotein. APB presence was observed in 31 patients (43%) already after the first autotransplant, the median interval from transplant was 2 months (range, 1 to 6 months). The most frequent occurrence of APB was observed after allogeneic transplantation. In the group of patients with APB presence more patients achieved complete remission (32.2% versus 17.1%), statistically significant differences were also established when we compared the percentage of surviving patients and overall survival, to the present date, among both groups of patients (p=0.03). All relapsed patients with previous isotype class switching had disease characterized by the same type of paraprotein as that detected at diagnosis. The development of APB is likely related to the recovery of impaired immunoglobulin production after transplantation. We confirmed favourable prognostic significance of this finding in transplanted myeloma patients.
- 000
- 03142naa 2200517 a 4500
- 001
- bmc10015063
- 003
- CZ-PrNML
- 005
- 20111210175742.0
- 008
- 100623s2007 xo e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xo
- 100 1_
- $a Maisnar, Vladimír $7 xx0062937
- 245 10
- $a Isotype class switching after transplantation in multiple myeloma / $c V Maisnar, M Tichy, L Smolej, P Zak, J Radocha, V Palicka, J Maly, V Blaha
- 314 __
- $a 2nd Department of Medicine-Department of Clinical Haematology, Charles University Teaching Hospital Hradec Králové, Czech Republic maisnar@fnhk.cz
- 520 9_
- $a Switching of the paraprotein isotype or transient presence of oligoclonal bands detectable by serum immunofixation electrophoresis has been reported following not only transplantations, but also after intensive chemotherapy for leukemia. Retrospective analysis of 72 transplanted myeloma patients was carried out to determine the frequency and clinical significance of the appearance of abnormal proteins bands (APB) distinct from the original paraprotein. APB presence was observed in 31 patients (43%) already after the first autotransplant, the median interval from transplant was 2 months (range, 1 to 6 months). The most frequent occurrence of APB was observed after allogeneic transplantation. In the group of patients with APB presence more patients achieved complete remission (32.2% versus 17.1%), statistically significant differences were also established when we compared the percentage of surviving patients and overall survival, to the present date, among both groups of patients (p=0.03). All relapsed patients with previous isotype class switching had disease characterized by the same type of paraprotein as that detected at diagnosis. The development of APB is likely related to the recovery of impaired immunoglobulin production after transplantation. We confirmed favourable prognostic significance of this finding in transplanted myeloma patients.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a nemoc štěpu proti hostiteli $7 D006086
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a přesmyk imunoglobulinových tříd $7 D017578
- 650 _2
- $a imunoglobulinové izotypy $x metabolismus $7 D007132
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a mnohočetný myelom $x imunologie $x patologie $x terapie $7 D009101
- 650 _2
- $a paraproteinemie $x patologie $7 D010265
- 650 _2
- $a paraproteiny $x imunologie $7 D010266
- 650 _2
- $a transplantace periferních kmenových buněk $7 D036102
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a míra přežití $7 D015996
- 650 _2
- $a homologní transplantace $7 D014184
- 700 1_
- $a Tichý, Miloš, $d 1941- $7 xx0112487
- 700 1_
- $a Smolej, Lukáš $7 xx0101489
- 700 1_
- $a Žák, Pavel, $d 1966- $7 mzk2006354145
- 700 1_
- $a Radocha, Jakub, $d 1981- $7 xx0233189
- 700 1_
- $a Palička, Vladimír, $d 1946- $7 jn99240000830
- 700 1_
- $a Malý, Jaroslav, $d 1946- $7 nlk19990073524
- 700 1_
- $a Bláha, Vladimír, $d 1964- $7 xx0002944
- 773 0_
- $t Neoplasma $w MED00003470 $g Roč. 54, č. 3 (2007), s. 225-228 $x 0028-2685
- 910 __
- $a ABA008 $b A 1194 $y 8
- 990 __
- $a 20100713094958 $b ABA008
- 991 __
- $a 20100713103046 $b ABA008
- 999 __
- $a ok $b bmc $g 750931 $s 614609
- BAS __
- $a 3
- BMC __
- $a 2007 $b 54 $c 3 $d 225-228 $i 0028-2685 $m Neoplasma $n Neoplasma $x MED00003470
- LZP __
- $a 2010-B1/mkme